Smiddy W E, Flynn H W
Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami School of Medicine, FL, USA.
Surv Ophthalmol. 1999 May-Jun;43(6):491-507. doi: 10.1016/s0039-6257(99)00036-3.
According to the Early Treatment Diabetic Retinopathy Study, at least 5% of eyes receiving optimal medical treatment will still have progressive retinopathy that requires laser treatment and pars plana vitrectomy. During the past decade, improvements in instrumentation and surgical techniques have allowed more difficult cases of diabetic retinopathy to be candidates for vitrectomy. However, although the thresholds for performing surgery within established indicated situations have been lowered, only a few additional indications have been established. Although vitrectomy improves the prognosis for a favorable visual outcome, preventive measures, such as improved control of glucose levels and timely application of panretinal photocoagulation, produce better results. The authors review the indications, techniques, and results of vitrectomy in the management of diabetic retinopathy.
根据早期糖尿病性视网膜病变研究,至少5%接受最佳药物治疗的眼睛仍会出现需要激光治疗和平坦部玻璃体切除术的进行性视网膜病变。在过去十年中,仪器设备和手术技术的改进使更多糖尿病性视网膜病变的疑难病例成为玻璃体切除术的候选对象。然而,尽管在既定的适应症范围内进行手术的阈值已经降低,但仅确立了少数其他适应症。尽管玻璃体切除术改善了获得良好视力结果的预后,但预防措施,如更好地控制血糖水平和及时进行全视网膜光凝,能产生更好的效果。作者回顾了玻璃体切除术在糖尿病性视网膜病变治疗中的适应症、技术和结果。